A Study of Revaree Plus in People With Breast Cancer

Clinical trial NCT07042581 · RECRUITING

Trial details

NCT number: NCT07042581
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Stage 0 Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Breast Cancer Stage 0 Breast Carcinoma Stage II Breast Carcinoma Stage III Breast Carcinoma Hormone-receptor-positive Breast Cancer Hormone Receptor Positive Breast Carcinoma Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2025-06-20
Primary completion: 2029-06-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.